@article{doka_suter_mastromauro_bennett_hess_2022, title={Doxorubicin for treatment of histiocytic sarcoma in dogs: 31 cases (2003-2017)}, volume={260}, ISSN={["1943-569X"]}, DOI={10.2460/javma.21.11.0498}, abstractNote={Abstract}, number={14}, journal={JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION}, author={Doka, Rhiannon M. and Suter, Steven E. and Mastromauro, Michael L. and Bennett, Ashley L. and Hess, Paul R.}, year={2022}, month={Nov}, pages={1827–1833} }
 @article{marin_mochizuki_mastromauro_stowe_2021, title={What is your diagnosis? Dermal mass in a dog}, volume={51}, ISSN={0275-6382 1939-165X}, url={http://dx.doi.org/10.1111/vcp.13015}, DOI={10.1111/vcp.13015}, abstractNote={Veterinary Clinical PathologyEarly View WHAT IS YOUR DIAGNOSIS? What is your diagnosis? Dermal mass in a dog Jessica Marin, Jessica Marin orcid.org/0000-0002-2451-2612 Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USASearch for more papers by this authorHiroyuki Mochizuki, Hiroyuki Mochizuki orcid.org/0000-0002-1520-0393 Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USASearch for more papers by this authorMichael Mastromauro, Michael Mastromauro Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USASearch for more papers by this authorDevorah M. Stowe, Corresponding Author Devorah M. Stowe damarks@ncsu.edu orcid.org/0000-0002-4058-2995 Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA Correspondence Devorah M. Stowe, Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, 1060 William Moore Drive, Raleigh, NC 27607, USA. Email: damarks@ncsu.eduSearch for more papers by this author Jessica Marin, Jessica Marin orcid.org/0000-0002-2451-2612 Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USASearch for more papers by this authorHiroyuki Mochizuki, Hiroyuki Mochizuki orcid.org/0000-0002-1520-0393 Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USASearch for more papers by this authorMichael Mastromauro, Michael Mastromauro Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USASearch for more papers by this authorDevorah M. Stowe, Corresponding Author Devorah M. Stowe damarks@ncsu.edu orcid.org/0000-0002-4058-2995 Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA Correspondence Devorah M. Stowe, Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, 1060 William Moore Drive, Raleigh, NC 27607, USA. Email: damarks@ncsu.eduSearch for more papers by this author First published: 04 November 2021 https://doi.org/10.1111/vcp.13015Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Early ViewOnline Version of Record before inclusion in an issue RelatedInformation}, number={1}, journal={Veterinary Clinical Pathology}, publisher={Wiley}, author={Marin, Jessica and Mochizuki, Hiroyuki and Mastromauro, Michael and Stowe, Devorah M.}, year={2021}, month={Nov}, pages={161–163} }
 @article{mochizuki_sherrick_mastromauro_stowe_2019, title={What is your diagnosis? Lymphocytes engulfing erythrocytes in a cat}, volume={48}, ISSN={0275-6382 1939-165X}, url={http://dx.doi.org/10.1111/vcp.12744}, DOI={10.1111/vcp.12744}, abstractNote={Veterinary Clinical PathologyVolume 48, Issue 4 p. 768-770 WHAT IS YOUR DIAGNOSIS? What is your diagnosis? Lymphocytes engulfing erythrocytes in a cat Hiroyuki Mochizuki, Hiroyuki Mochizuki orcid.org/0000-0002-1520-0393 Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North CarolinaSearch for more papers by this authorEllen Sherrick, Ellen Sherrick Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North CarolinaSearch for more papers by this authorMichael Mastromauro, Michael Mastromauro Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North CarolinaSearch for more papers by this authorDevorah Marks Stowe, Corresponding Author Devorah Marks Stowe damarks@ncsu.edu Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina Correspondence Devorah Marks Stowe, Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, 1060 William Moore Drive, Raleigh, NC 27607, USA. Email: damarks@ncsu.eduSearch for more papers by this author Hiroyuki Mochizuki, Hiroyuki Mochizuki orcid.org/0000-0002-1520-0393 Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North CarolinaSearch for more papers by this authorEllen Sherrick, Ellen Sherrick Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North CarolinaSearch for more papers by this authorMichael Mastromauro, Michael Mastromauro Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North CarolinaSearch for more papers by this authorDevorah Marks Stowe, Corresponding Author Devorah Marks Stowe damarks@ncsu.edu Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina Correspondence Devorah Marks Stowe, Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, 1060 William Moore Drive, Raleigh, NC 27607, USA. Email: damarks@ncsu.eduSearch for more papers by this author First published: 28 June 2019 https://doi.org/10.1111/vcp.12744Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume48, Issue4December 2019Pages 768-770 This article also appears in:What is your diagnosis? Virtual Issue RelatedInformation}, number={4}, journal={Veterinary Clinical Pathology}, publisher={Wiley}, author={Mochizuki, Hiroyuki and Sherrick, Ellen and Mastromauro, Michael and Stowe, Devorah Marks}, year={2019}, month={Jun}, pages={768–770} }
 @article{mastromauro_suter_hauck_hess_2017, title={Oral melphalan for the treatment of relapsed canine lymphoma}, volume={16}, ISSN={1476-5810}, url={http://dx.doi.org/10.1111/vco.12356}, DOI={10.1111/vco.12356}, abstractNote={Oral melphalan has been included in multi‐agent rescue protocols for canine lymphoma but its activity as a single‐agent for this purpose has not been established. Inexpensive cost, ease of administration and tolerability make oral melphalan an attractive candidate for single‐agent rescue therapy of canine lymphoma. Retrospective evaluation of 19 cases of relapsed canine lymphoma treated with oral melphalan was performed. Melphalan was primarily administered (n = 16) via a high dose protocol (HDM) with a median dosage of 19.4 mg m−2. Fifteen dogs (78.9%) were treated concurrently with corticosteroids. Response evaluation was possible for all dogs with a calculated overall clinical benefit (partial response [PR] + stable disease [SD]) of 31.6% (PR 3/19; SD 3/19). Times to progression following melphalan (TTP‐M) were 14, 24 and 34 days for responders and 20, 28 and 103 days for dogs experiencing SD. Twelve of 17 dogs evaluable for toxicity experienced an adverse event (AE) with only 3 dogs experiencing a grade III or higher AE. Haematologic toxicity was common (11/17) while gastrointestinal toxicity was rare (1/17). Although treatment resulted in limited clinical benefit and non‐durable responses, oral melphalan was well‐tolerated and may be a reasonable rescue option in cases where minimal effective agents remain.}, number={1}, journal={Veterinary and Comparative Oncology}, publisher={Wiley}, author={Mastromauro, M. L. and Suter, S. E. and Hauck, M. L. and Hess, P. R.}, year={2017}, month={Sep}, pages={E123–E129} }